Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Allogene Therapeutics (ALLO) Tax Provisions (2019)

Allogene Therapeutics (ALLO) has disclosed Tax Provisions for 1 consecutive years, with -$131000.0 as the latest value for Q4 2019.

  • Quarterly Tax Provisions changed N/A to -$131000.0 in Q4 2019 from the year-ago period, while the trailing twelve-month figure was -$131000.0 through Sep 2020, changed N/A year-over-year, with the annual reading at $443000.0 for FY2024, N/A changed from the prior year.
  • Tax Provisions hit -$131000.0 in Q4 2019 for Allogene Therapeutics, up from -$200000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of -$100000.0 in Q1 2019 to a low of -$200000.0 in Q2 2019.